VANCOUVER – The University of British Columbia is creating a new professorship to study the potential role of marijuana to treat opjojdiku habit, change the faculty members say will begin to fill gap in research on cannabis.
Epidemjologu and scientist of M J Milloy research was appointed as the professor of Canopy Growth in cannabis science at the university.
"Dr. MJ Milloy will be the first professor of science of Canada of Canada at the University & # 39; British Columbia and the first professor in Canada focused on research on cannabis can & # 39 ; be in crisis & # 39; overdose. Friday.
Between January and September, more than 1,100 people died from suspected & # 39; overdose & # 39; opioids, according to the ministry.
Milloy will conduct clinical trials to explore how cannabis can & # 39; helping people with & # 39; disturbance to the use of & # 39; opioid stay on their treatment plans, said the ministry.
Researching & # 39; Milloy has already shown that the use of & # 39; daily cannabis was linked & # 39; increased likelihood that people hold treatment and lower risk & # 39; young people involved in road start injecting drugs.
As a first step in the new position, Milloy said he wants to build on a preliminary study & # 39; 2,500 drug users in the Downtown Eastside of & # 39; Vancouver. That study showed that individuals who were starting methadone or suboxone, which are the first-line therapies for the disorder to use & # 39; opioids, were more than 20 percent more likely to be still on treatment for six months if they are using cannabis daily. said.
"What we would do as the next step is to test that association in a clinical trial," said Milloy.
Milloy has written more than 150 peer-reviewed article about how the policy can & # 39; affecting the health outcomes for people who use drugs.
The company Marijuana Growth Canopy is contributing $ 2.5 million, while the province is paying $ 500,000 to UBC and the BC Center on Substance Use for the position.
Dr. Dermot Kelleher, dean of UBC faculty of medicine, said the university has established protocols to prevent conflicts & # 39; & # 39 related interest; funded research companies.
Mark Ware, the chief of the Growth Canopy & # 39; s, said that research on cannabis was limited by a ban, which made it difficult to collect accurate information such as prevalence and patterns & # 39; use as illegal substance.
The stigma around drug also bled the academic sphere and limited people to take science cannabis seriously, said Ware, who is also a former executive director of the Canadian Consortium pointless & # 39; profit for -Investigazzjoni of & # 39; Cannabinoids and taught in the faculty & # 39; McGill University family medicine.
"For many reasons, the drug was & # 39; challenging and probably will continue to be. This is not end overnight. We continue to face questions on the interpretation and importance of research on cannabis , so I think we are discussing but we still remain & # 39; a long way to go ", said Ware.
Dr. Evan Wood, director of the BC Center on Substance Use and professor at UBC faculty of medicine, said that research will help to fill a gap.
"This professorship is not only a step much needed in & # 39; field & # 39; study neglected as a result of & # 39; ban, but it is also a unique combination of & # 39; people in all sectors to address question & # 39; urgent and pressing health that affects our country, "Wood said.